TXG

Torex adds a seasoned mining finance expert to its board amid stable governance.

Torex Gold delivers strong Q3 production and accelerates capital returns to shareholders.

Torex Gold advances Morelos drilling with high-grade intercepts and a record $51M exploration budget.

10x Genomics wins $4.8 million jury award against Qiagen’s Parse for patent infringement.

Torex delivers strong Q2 profits and cash flow, but cost pressures persist.

10x Genomics and CHUV launch a multi-year cancer research study with no immediate financial impact.

Torex Gold’s drilling update is technically detailed but lacks any near-term investment catalyst.

Big numbers, but all projections—no cash flow, no reserves, and years from reality.

Solid operations, but too many promises and not enough financial detail for conviction.

Acquisition is long on vision, short on numbers—wait for real results before acting.

Torex is spending big on exploration, but results and value are still years away.

Torex delivers real ESG progress, but financial and production details remain out of sight.

Financials are improving, but product hype outpaces hard evidence—watch for real traction.

Torex Gold posts record Q1 results, but future growth still hinges on execution in Mexico.

Torex promises big 2026 payouts, but proof and details are still missing.

Big drill results, but no new resources or financials—future value is still unproven.